List of Excipients in API metformin hcl
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing metformin hcl
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| QPharma Inc | metformin hcl | 42708-009 | HYPROMELLOSE 2910 |
| QPharma Inc | metformin hcl | 42708-009 | MAGNESIUM STEARATE |
| QPharma Inc | metformin hcl | 42708-009 | MALTODEXTRIN |
| QPharma Inc | metformin hcl | 42708-009 | POLYETHYLENE GLYCOL 400 |
| QPharma Inc | metformin hcl | 42708-009 | POVIDONE K30 |
| QPharma Inc | metformin hcl | 42708-009 | POVIDONE K90 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for metformin hcl
Excipient focus: CELLULOSE, MICROCRYSTALLINE
metformin hcl drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
metformin hcl drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: HYPROMELLOSE 2910
metformin hcl drug variants containing HYPROMELLOSE 2910
metformin hcl drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
metformin hcl drug variants containing MAGNESIUM STEARATE
metformin hcl drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
metformin hcl drug variants containing MALTODEXTRIN
metformin hcl drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
metformin hcl drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
metformin hcl drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
metformin hcl drug variants containing POLYETHYLENE GLYCOL 400
metformin hcl drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
metformin hcl drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
metformin hcl drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
metformin hcl drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
metformin hcl drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
metformin hcl drug variants containing POVIDONE K30
metformin hcl drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
metformin hcl drug variants containing POVIDONE K90
metformin hcl drug variants not containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
metformin hcl drug variants containing STARCH, CORN
metformin hcl drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
metformin hcl drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
metformin hcl drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
metformin hcl drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
metformin hcl drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
metformin hcl drug variants containing TRIACETIN
metformin hcl drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| TIME CAP LABORATORIES INC | metformin hcl | 49483-620 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
